Quality of Life Effects of Ovarian Suppression in the Suppression of Ovarian Function Trial

被引：1
|
作者：
Tomao, Federica [1 ,2 ]
Papa, Anselmo
Tomao, Silverio [3 ]
机构：
[1] European Inst Oncol, Milan, Italy
[2] Univ Rome Sapienza, Rome, Italy
[3] Univ Rome Sapienza, Latina, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 34期
关键词：
PREMENOPAUSAL BREAST-CANCER; PATIENT-REPORTED OUTCOMES; ADJUVANT EXEMESTANE; ENDOCRINE TREATMENT; WOMEN; TAMOXIFEN;
D O I：
10.1200/JCO.2016.68.8218
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4188 / +
页数：2
相关论文
共 50 条
  • [31] Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor
    Jordan, Jennifer H.
    D'Agostino, Ralph B.
    Ansley, Katherine
    Douglas, Emily
    Melin, Susan
    Sorscher, Steven
    Vasu, Sujethra
    Park, Sung
    Kotak, Anuj
    Romitti, Paul A.
    O'Connell, Nathanial S.
    Hundley, William G.
    Thomas, Alexandra
    JNCI CANCER SPECTRUM, 2021, 5 (04)
  • [32] OVARIAN HYPERSTIMULATION ASSOCIATED WITH THE SOLE USE OF LEUPROLIDE FOR OVARIAN SUPPRESSION
    YEH, J
    BARBIERI, RL
    RAVNIKAR, VA
    JOURNAL OF IN VITRO FERTILIZATION AND EMBRYO TRANSFER, 1989, 6 (04): : 261 - 263
  • [33] SOFT trial endorses selective ovarian suppression in early breast cancer
    Jancin, Bruce
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2015, 13 (01): : 31 - 31
  • [34] Re: Ovarian ablation or suppression in premenopausal early breast cancer: Results from the International Adjuvant Breast Cancer ovarian Ablation or Suppression Randomized Trial
    Ferretti, Gianluigi
    Felici, Alessandra
    Carlini, Paolo
    Cognetti, Francesco
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (17): : 1344 - 1345
  • [35] ROSE trial: A prospective non-interventional study to assess the quality of life (QoL) of premenopausal patients with early breast cancer receiving triptorelin as ovarian function suppression
    Mauri, G.
    Perrot, V.
    Mazzanti, P.
    De laurentiis, M.
    Pagani, O.
    Munzone, E.
    BREAST, 2023, 68 : S15 - S16
  • [36] Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer
    Xue, Cong
    Peng, Roujun
    Cao, Ye
    Wang, Shusen
    Shi, Yanxia
    An, Xin
    Xu, Fei
    Yuan, Zhongyu
    PLOS ONE, 2016, 11 (02):
  • [37] IMMUNE SUPPRESSION BY OVARIAN-CELLS
    VANDEPUTTE, M
    VANVLASSELAER, P
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1984, 6 (02): : 66 - 66
  • [38] OVARIAN SUPPRESSION AND BREAST-CANCER
    WEICK, JK
    COOPERMAN, AM
    SURGICAL CLINICS OF NORTH AMERICA, 1978, 58 (04) : 795 - 800
  • [39] TREATMENT OF HIRSUTISM BY ADRENAL AND OVARIAN SUPPRESSION
    CASEY, JH
    BURGER, HG
    KENT, JR
    KELLIE, AE
    MOXHAM, A
    NABARRO, J
    NABARRO, JDN
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1966, 26 (12): : 1370 - +
  • [40] Methods of ovarian suppression used in the UK
    Featherstone, CJ
    Harnett, AN
    Brunt, AM
    Johnson, L
    BREAST, 2002, 11 (01): : 23 - 29
12345